Cellabs Competitors and Similar CompaniesClear all

BioCryst Pharmaceuticals's competitors and similar companies include Fortress Biotech.
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
Fortress Biotech
Fortress Biotech
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
Founding Date
Founding Date
1986
Founding Date
2006
Type
Type
Public
Type
Public
Tags
Locations
Locations
Durham, US HQ
Hoover, US
Locations
New York, US HQ
Waltham, US
Employees
Employees
14040% increase
Employees
10146% decrease
Valuation ($)
Valuation ($)
1.7 b
Valuation ($)
55.7 m

Financial

Revenue (est.)
Revenue (est.)
$874.8m (FY, 2025)
Revenue (est.)
$63.3m (FY, 2025)
Cost of goods
Cost of goods
$19.1m (FY, 2025)
Cost of goods
$20.9m (FY, 2025)
Gross profit
Gross profit
$855.8m (FY, 2025)
Gross profit
$42.3m (FY, 2025)
Net income
Net income
$263.9m (FY, 2025)
Net income
($32.9m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Fortress Biotech
HQ
New York, US
Employees
101↓ 46% decrease

Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.

View company